| # | Drug | Count |
|---|---|---|
| 0 | BORTEZOMIB | 7 |
| 1 | CYCLOPHOSPHAMIDE | 7 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 4 | DEXAMETHASONE | 7 |
| 5 | DEXAMETHASONE 1.5 MG | 7 |
| 6 | POMALIDOMIDE | 7 |
| 7 | LENALIDOMIDE | 6 |
| 8 | MELPHALAN HYDROCHLORIDE | 6 |
| 9 | SOTALOL HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBUMIN HUMAN | 3 | 0.0006 |
| 1 | ALBUMIN (HUMAN) | 3 | 0.0005 |
| 2 | VINORELBINE | 3 | 0.0004 |
| 3 | SOTALOL HYDROCHLORIDE | 6 | 0.0004 |
| 4 | ESTROGEN | 1 | 0.0003 |
| 5 | MELPHALAN HYDROCHLORIDE | 6 | 0.0002 |
| 6 | ELOSULFASE ALFA | 1 | 0.0002 |
| 7 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 8 | EXEMESTANE | 3 | 0.0001 |
| 9 | ANASTROZOLE TABLETS | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9 |
| 1 | Alkylating Drug [EPC] | 7 |
| 2 | Proteasome Inhibitor [EPC] | 7 |
| 3 | Thalidomide Analog [EPC] | 7 |
| 4 | Aromatase Inhibitor [EPC] | 3 |
| 5 | Kinase Inhibitor [EPC] | 3 |
| 6 | Microtubule Inhibitor [EPC] | 3 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 8 | Platinum-based Drug [EPC] | 3 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Proteasome Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 4 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Antidote [EPC] | 1 | 0.0000 |
| 7 | Thalidomide Analog [EPC] | 7 | 0.0000 |
| 8 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |